# Verrica Pharmaceuticals Inc.: filings

VRCA · Nasdaq · CIK 1660334 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vrca.md) · [Financials](/companies/vrca/financials.md) · [Filings](/companies/vrca/filings.md) · [Insiders](/companies/vrca/insiders.md)

## Reports and events: 158 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 215, 8-K 110, 3 26, 10-Q 25, 144 18, SC 13G/A 16, S-8 11, 4/A 10, CORRESP 9, 10-K 8, 424B5 8, DEF 14A 8, DEFA14A 8, SCHEDULE 13G/A 7, UPLOAD 7, EFFECT 5, SC 13G 5, ARS 4, D 4, S-3 4, SCHEDULE 13G 3, SCHEDULE 13D/A 2, SEC STAFF LETTER 2, 144/A 1, 3/A 1, 424B3 1, 424B4 1, 5 1, 8-A12B 1, CERT 1, CT ORDER 1, DEFR14A 1, DRS 1, DRS/A 1, DRSLTR 1, FWP 1, PRE 14A 1, S-1 1, S-1/A 1, SC 13D 1, SC 13D/A 1, SCHEDULE 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-06 | 16:37 ET | [10-Q](/filings/0001660334-26-000025.md) | Quarterly report, period 2026-06-30 | 0001660334-26-000025 |
| 2026-08-06 | 16:34 ET | [8-K](/filings/0001193125-26-338273.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-338273 |
| 2026-06-09 | 16:05 ET | [8-K](/filings/0001193125-26-263722.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-263722 |
| 2026-05-12 | 16:15 ET | [10-Q](/filings/0001660334-26-000014.md) | Quarterly report, period 2026-03-31 | 0001660334-26-000014 |
| 2026-05-12 | 16:07 ET | [8-K](/filings/0001193125-26-219395.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-219395 |
| 2026-04-20 | 16:10 ET | [DEF 14A](/filings/0001193125-26-163961.md) | Proxy statement, period 2026-06-05 | 0001193125-26-163961 |
| 2026-03-11 | 08:11 ET | [10-K](/filings/0001660334-26-000008.md) | Annual report, period 2025-12-31 | 0001660334-26-000008 |
| 2026-03-11 | 08:08 ET | [8-K](/filings/0001193125-26-101126.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-101126 |
| 2025-12-30 | 07:10 ET | [SCHEDULE 13D/A](/filings/0000902664-25-005417.md) | Ownership report, active investor, amended | 0000902664-25-005417 |
| 2025-12-30 | 06:05 ET | [8-K](/filings/0001193125-25-335824.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-335824 |
| 2025-11-28 | 17:10 ET | [SCHEDULE 13D/A](/filings/0001494695-25-000006.md) | Ownership report, active investor, amended | 0001494695-25-000006 |
| 2025-11-24 | 16:15 ET | [SCHEDULE 13D](/filings/0000902664-25-005145.md) | Ownership report, active investor | 0000902664-25-005145 |
| 2025-11-24 | 08:19 ET | [8-K](/filings/0001193125-25-292155.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-292155 |
| 2025-11-14 | 16:34 ET | [10-Q](/filings/0001660334-25-000006.md) | Quarterly report, period 2025-09-30 | 0001660334-25-000006 |
| 2025-11-14 | 16:25 ET | [8-K](/filings/0001193125-25-283078.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-283078 |
| 2025-08-12 | 16:20 ET | [10-Q](/filings/0000950170-25-107358.md) | Quarterly report, period 2025-06-30 | 0000950170-25-107358 |
| 2025-08-12 | 16:11 ET | [8-K](/filings/0001193125-25-178954.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-178954 |
| 2025-07-30 | 16:15 ET | [8-K](/filings/0001193125-25-169309.md) | 3.01 Delisting notice | 0001193125-25-169309 |
| 2025-07-23 | 08:00 ET | [8-K](/filings/0001193125-25-162939.md) | 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001193125-25-162939 |
| 2025-07-01 | 08:02 ET | [8-K](/filings/0001193125-25-153471.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-153471 |
| 2025-06-12 | 16:27 ET | [8-K](/filings/0001193125-25-139959.md) | 1.01 Entry into a material agreement | 0001193125-25-139959 |
| 2025-06-05 | 16:57 ET | [8-K](/filings/0001193125-25-135949.md) | 5.07 Shareholder vote results | 0001193125-25-135949 |
| 2025-05-13 | 16:36 ET | [10-Q](/filings/0000950170-25-070452.md) | Quarterly report, period 2025-03-31 | 0000950170-25-070452 |
| 2025-05-13 | 16:19 ET | [8-K](/filings/0001193125-25-118839.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-118839 |
| 2025-04-25 | 16:21 ET | [8-K](/filings/0001193125-25-096909.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-096909 |
| 2025-04-22 | 07:15 ET | [DEF 14A](/filings/0001193125-25-087838.md) | Proxy statement, period 2025-06-05 | 0001193125-25-087838 |
| 2025-04-02 | 16:31 ET | [8-K](/filings/0001193125-25-071389.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-071389 |
| 2025-03-11 | 16:23 ET | [10-K](/filings/0000950170-25-037172.md) | Annual report, period 2024-12-31 | 0000950170-25-037172 |
| 2025-03-11 | 16:15 ET | [8-K](/filings/0001193125-25-051957.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-051957 |
| 2025-02-21 | 16:15 ET | [8-K](/filings/0001193125-25-032003.md) | 1.01 Entry into a material agreement | 0001193125-25-032003 |
| 2025-01-30 | 16:16 ET | [8-K](/filings/0001193125-25-017264.md) | 3.01 Delisting notice | 0001193125-25-017264 |
| 2024-12-09 | 16:10 ET | [8-K](/filings/0001193125-24-273406.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-273406 |
| 2024-11-26 | 16:15 ET | [SC 13D/A](/filings/0001104659-24-123093.md) | Ownership report, active investor, amended | 0001104659-24-123093 |
| 2024-11-21 | 16:55 ET | [8-K](/filings/0001193125-24-263477.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-263477 |
| 2024-11-20 | 17:08 ET | [8-K](/filings/0001193125-24-262615.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-262615 |
| 2024-11-05 | 18:25 ET | [10-Q](/filings/0000950170-24-120982.md) | Quarterly report, period 2024-09-30 | 0000950170-24-120982 |
| 2024-11-04 | 16:17 ET | [8-K](/filings/0001193125-24-250638.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-250638 |
| 2024-10-08 | 16:16 ET | [8-K](/filings/0001193125-24-234391.md) | 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors | 0001193125-24-234391 |
| 2024-10-01 | 16:37 ET | [8-K](/filings/0001193125-24-230240.md) | 2.05 Exit or disposal costs | 0001193125-24-230240 |
| 2024-09-27 | 16:15 ET | [8-K](/filings/0001193125-24-227975.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-227975 |
| 2024-09-06 | 16:16 ET | [8-K](/filings/0001193125-24-215180.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-215180 |
| 2024-08-27 | 16:50 ET | [8-K](/filings/0001193125-24-207814.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-207814 |
| 2024-08-14 | 08:07 ET | [10-Q](/filings/0000950170-24-096669.md) | Quarterly report, period 2024-06-30 | 0000950170-24-096669 |
| 2024-08-14 | 07:56 ET | [8-K](/filings/0001193125-24-200247.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-200247 |
| 2024-08-05 | 16:15 ET | [8-K](/filings/0001193125-24-193923.md) | 1.01 Entry into a material agreement | 0001193125-24-193923 |
| 2024-06-28 | 16:17 ET | [8-K](/filings/0001193125-24-172277.md) | 1.01 Entry into a material agreement | 0001193125-24-172277 |
| 2024-06-10 | 16:18 ET | [8-K](/filings/0001193125-24-158353.md) | 5.07 Shareholder vote results | 0001193125-24-158353 |
| 2024-05-15 | 07:45 ET | [8-K](/filings/0001193125-24-138898.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-138898 |
| 2024-05-13 | 08:01 ET | [10-Q](/filings/0000950170-24-058208.md) | Quarterly report, period 2024-03-31 | 0000950170-24-058208 |
| 2024-05-13 | 07:46 ET | [8-K](/filings/0001193125-24-136715.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-136715 |

Page 1 of 4. [Older](/companies/vrca/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.